Prophylactic Therapy Using Epigenetic Agents for RUNX1::RUNXT1-positive High-Risk AML after Allo-HSCT
Annals of Hematology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined